Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Cell Cycle/DNA Damage-PARP-Nesuparib
Nesuparib

Chemical Structure : Nesuparib

CAS No.: 2055357-64-5

Nesuparib (JPI-547, NOV140201)

Catalog No.: PC-73432Not For Human Use, Lab Use Only.

Nesuparib (JPI-547, NOV140201) is a potent, oral, dual inhibitor of PARP 1/2 and Tankyrase 1/2, demonstrates anti-tumor activity in BRCA-deficient cancer.

Packing Price Stock Quantity
5 mg $188 In stock
10 mg $298 In stock
25 mg $498 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Nesuparib (JPI-547, NOV140201) is a potent, oral, dual inhibitor of PARP 1/2 and Tankyrase 1/2, demonstrates anti-tumor activity in BRCA-deficient cancer.
Nesuparib (JPI-547, NOV140201) shows anti-tumor activity in BRCA-deficient xenograft models as a single-agent and in combination with chemotherapy and immune checkpoint inhibitors.

Physicochemical Properties

M.Wt 400.486
Formula C23H24N6O
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

3-Pyridinecarbonitrile, 6-[4-[(1,2,3,4,5,6-hexahydro-5-oxobenzo[h]-1,6-naphthyridin-8-yl)methyl]-1-piperazinyl]-

References

1. Seock-Ah Im, et al. 2021 ASCO Annual Meeting I.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: